Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells

Yulong Gao,Fernando Souza-Fonseca-Guimaraes,Tobias Bald,Susanna S Ng,Arabella Young,Shin Foong Ngiow,Jai Rautela,Jasmin Straube,Nic Waddell,Stephen J Blake,Juming Yan,Laurent Bartholin,Jason S Lee,Eric Vivier,Kazuyoshi Takeda,Meriem Messaoudene,Laurence Zitvogel,Michele W L Teng,Gabrielle T Belz,Christian R Engwerda,Nicholas D Huntington,Kyohei Nakamura,Michael Hölzel,Mark J Smyth
DOI: https://doi.org/10.1038/ni.3800
IF: 30.5
2017-07-31
Nature Immunology
Abstract:How tumors evade control by natural killer cells is ill defined. Smyth and colleagues show that natural killer cells in the tumor microenvironment can convert into type I innate lymphoid cells and intermediate type I innate lymphoid cells that favor tumor growth and metastasis.
immunology
What problem does this paper attempt to address?